Original Source(s)
Related Content
FDA clears at-home risankizumab induction
Week 12 remission reached 56% vs. 30% with placebo, with the FDA revising tuberculosis testing precautions.
by Teraya Smith
October 23, 2026
-
2 min
Lupus nephritis may remit despite HIV
A patient with biopsy-confirmed renal disease achieved remission during immunosuppressive therapy while maintaining stable HIV control.
October 23, 2026
-
4 min
Targeting bone marrow pathway may curb bone loss
Researchers identify a pathway connecting bone marrow fat accumulation, inflammation, and impaired bone formation, with combined treatment preserving skeletal structure in aging mice.
October 19, 2026
-
4 min
